SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development
暂无分享,去创建一个
E. Yu | Jene Choi | C. Sung | C. Kim | S. Yoo | Ji-Young Song | Nayoung Kim | H. Kang | Dal-Hee Chung | Sy-Hye Lee | Ji-Young Song
[1] A. Galli,et al. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. , 2014, World journal of gastroenterology.
[2] Asif Ali,et al. Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism , 2014, Journal of Inflammation.
[3] P. Lai,et al. HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma , 2013, British Journal of Cancer.
[4] Jianhua Yang,et al. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer , 2013, Protein & Cell.
[5] Eun-Sook Park,et al. HBx-Induced NF-κB Signaling in Liver Cells Is Potentially Mediated by the Ternary Complex of HBx with p22-FLIP and NEMO , 2013, PloS one.
[6] Hongyang Wang,et al. Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis , 2012, Frontiers of Medicine.
[7] Yan Wang,et al. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.
[8] T. Han,et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. , 2011, Cancer cell.
[9] T. Luedde,et al. NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma , 2011, Nature Reviews Gastroenterology &Hepatology.
[10] M. Kew. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.
[11] M. Karin,et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.
[12] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[13] M. Karin,et al. NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.
[14] Y. Agazie,et al. SHP2 is up‐regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis , 2008, Histopathology.
[15] Seung-Oe Lim,et al. HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species. , 2008, Virus research.
[16] B. Neel,et al. The tyrosine phosphatase Shp2 (PTPN11) in cancer , 2008, Cancer and Metastasis Reviews.
[17] Sung Gyoo Park,et al. Interferon‐γ sensitizes hepatitis B virus‐expressing hepatocarcinoma cells to 5‐fluorouracil through inhibition of hepatitis B virus‐mediated nuclear factor‐κB activation , 2007 .
[18] S. Maher,et al. Interferon: cellular executioner or white knight? , 2007, Current medicinal chemistry.
[19] Hana Kim,et al. A Fourth IκB Protein within the NF-κB Signaling Module , 2007, Cell.
[20] J. Ou,et al. Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice , 2007, Hepatology.
[21] A. Hoffmann,et al. Transcriptional regulation via the NF-κB signaling module , 2006, Oncogene.
[22] N. Droin,et al. Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection , 2006, Molecular and Cellular Biology.
[23] M. Arsura,et al. Nuclear factor-κB and liver carcinogenesis , 2005 .
[24] M. Bouchard,et al. The Enigmatic X Gene of Hepatitis B Virus , 2004, Journal of Virology.
[25] M. Loh,et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. , 2004, Blood.
[26] J. Licht,et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia , 2003, Nature Genetics.
[27] B. Neel,et al. The "Gab" in signal transduction. , 2003, Trends in cell biology.
[28] X. Wang,et al. Molecular pathogenesis of human hepatocellular carcinoma. , 2002, Toxicology.
[29] Sun Park,et al. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. , 2002, Cancer letters.
[30] Ping Liu,et al. Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas , 2002 .
[31] Yan Liu,et al. The gift of Gab , 2002, FEBS letters.
[32] Jie Wu,et al. Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2* , 2001, The Journal of Biological Chemistry.
[33] R. Lucito,et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.
[34] R. Schneider,et al. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Natoli,et al. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.
[36] W. Rutter,et al. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] K. Matsubara,et al. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. , 1993, Virology.
[38] A. Siddiqui,et al. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.
[39] P. Mitchell,et al. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors , 1990, Nature.
[40] M. Karin,et al. NF-κB and STAT3 – key players in liver inflammation and cancer , 2011, Cell Research.
[41] Hong Zheng,et al. SHP-2 tyrosine phosphatase in human diseases. , 2009, International journal of clinical and experimental medicine.
[42] Tara L. Kieffer,et al. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .
[43] Sung Gyoo Park,et al. Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation. , 2007, Cancer science.
[44] Hana Kim,et al. A fourth IkappaB protein within the NF-kappaB signaling module. , 2007, Cell.
[45] A. Hoffmann,et al. Transcriptional regulation via the NF-kappaB signaling module. , 2006, Oncogene.
[46] M. Arsura,et al. Nuclear factor-kappaB and liver carcinogenesis. , 2005, Cancer letters.
[47] C. Degott,et al. Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. , 2002, Journal of Hepatology.
[48] T. Heinemeyer,et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL , 1998, Nucleic Acids Res..